↓ Skip to main content

Developments and challenges of FLT3 inhibitors in acute myeloid leukemia

Overview of attention for article published in Frontiers in oncology, September 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
25 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Developments and challenges of FLT3 inhibitors in acute myeloid leukemia
Published in
Frontiers in oncology, September 2022
DOI 10.3389/fonc.2022.996438
Pubmed ID
Authors

Shuai-Shuai Ge, Song-Bai Liu, Sheng-Li Xue

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 7 28%
Student > Ph. D. Student 2 8%
Researcher 1 4%
Lecturer > Senior Lecturer 1 4%
Student > Bachelor 1 4%
Other 3 12%
Unknown 10 40%
Readers by discipline Count As %
Unspecified 7 28%
Medicine and Dentistry 4 16%
Biochemistry, Genetics and Molecular Biology 1 4%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Nursing and Health Professions 1 4%
Other 1 4%
Unknown 10 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 October 2022.
All research outputs
#18,174,939
of 26,588,416 outputs
Outputs from Frontiers in oncology
#8,431
of 23,330 outputs
Outputs of similar age
#259,651
of 440,378 outputs
Outputs of similar age from Frontiers in oncology
#668
of 1,805 outputs
Altmetric has tracked 26,588,416 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 23,330 research outputs from this source. They receive a mean Attention Score of 3.0. This one has gotten more attention than average, scoring higher than 57% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,378 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,805 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.